Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | ADH1B | P00325 | 1/20 | 0.45 |
| ▸ | ADH1C | P00326 | 1/20 | 0.45 |
| ▸ | ADH1A | P07327 | 1/20 | 0.45 |
| ▸ | ADH7 | P40394 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL21552856 | 0.98 | MAPT (0.58) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL26670320 | 0.88 | ALDH1A1 (0.53) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL13185941 | 0.80 | CHRM2 (0.53) | MEN1KMT2AMAPTKDM4ECYP3A4 | |
| Water SCHEMBL11666905 | 0.80 | MEN1 (0.74) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL6663240 | 0.78 | LMNA (0.59) | MEN1KMT2ACYP3A4CHRM2 | |
| SCHEMBL11305587 | 0.78 | CHRM2 (0.52) | MEN1KMT2ATDP1KDM4ECHRM2 | |
| SCHEMBL2238594 | 0.78 | CA12 (0.57) | MAPTCYP3A4MAOAGAATSHR | |
| SCHEMBL11445734 | 0.78 | ANPEP (0.42) | TDP1CYP3A4MAOATSHR | |
| SCHEMBL421501 | 0.78 | MEN1 (0.64) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL26672005 | 0.78 | PYCR1 (0.66) | MEN1KMT2AMAPTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117696115-A | PDI/g-C 3 N 4 Z-type heterojunction catalyst and preparation method and application thereof | 青岛科技大学 | 2024-03-15 | — | — | CN | claimed |
| CN-102531888-A | Chemical synthesis method of 3,4,5-trimethoxy benzoyl chloride | UNIV WENZHOU | 2012-07-04 | — | — | CN | claimed |
| JP-6100543-A | — | — | None | — | — | JP | disclosed |
| US-20250353853-A1 | FLAVIVIRUS INHIBITORS | IRBM S.P.A. (IT) | 2025-11-20 | — | — | US | disclosed |
| EP-4532476-A1 | FLAVIVIRUS INHIBITORS | IRBM S.P.A. (IT) | 2025-04-09 | — | — | EP | disclosed |
| CN-115515685-B | EIF4E inhibitors and uses thereof | 皮克医疗公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119707724-A | Glycine (II)14Process for the preparation of C | 长沙贝塔医药科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-4523755-A2 | QUINAZOLINE DERIVATIVES AS ANTITUMOR AGENTS | F. Hoffmann-La Roche AG (CH) | 2025-03-19 | — | — | EP | disclosed |
| CN-119630645-A | Flavivirus inhibitors | IRBM股份公司 | 2025-03-14 | — | — | CN | disclosed |
| US-20250002495-A1 | SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME | TENACIA BIOTECHNOLOGY HONG KONG CO LTD (HK) | 2025-01-02 | — | — | US | disclosed |
| US-20240425476-A1 | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS | ASTRAZENECA AB (SE) | 2024-12-26 | — | — | US | disclosed |
| US-4559371-A | FOR PRINTING INKS AND PAINTS | CIBA GEIGY CORPORATION (US) | 1985-12-17 | — | — | US | disclosed |
| US-4525311-A | O,O-Dialkyl-N-(benzyl or t-butyl)-N-cyanomethyl aminomethylphosphonates | STAUFFER CHEMICAL COMPANY (US) | 1985-06-25 | — | — | US | disclosed |
| EP-0117233-A1 | Coloured photo-curable mouldings | CIBA-GEIGY AG (CH) | 1984-08-29 | — | — | EP | disclosed |
| US-4447446-A | PESTICIDE, HERBICIDE | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1984-05-08 | — | — | US | disclosed |
| US-4421693-A | INSECTICIDES, MITICIDES OR NEMATOCIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 1983-12-20 | — | — | US | disclosed |
| US-4413005-A | 2,3-DIHYDRO-2,2-DIMETHYLBENZOFURAN-7-YL DERIVATIVES | OTSUKA KAGAKU YAKUHIN KABUSHIKI KAISHA (JP) | 1983-11-01 | — | — | US | disclosed |
| EP-0088050-A2 | Coloured photo-hardenable composition | CIBA-GEIGY AG (CH) | 1983-09-07 | — | — | EP | disclosed |
| EP-0059536-A2 | Amide derivatives, processes for preparing them, their use as fungicides and pesticidal compositions containing them | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1982-09-08 | — | — | EP | disclosed |
| US-4134889-A | Manufacture of glycinonitriles | BASF AKTIENGESELLSCHAFT (DE) | 1979-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240425476-A1 | 2-(2,4,5-SUBSTITUTED-ANILINO)PYRIMIDINE COMPOUNDS | EGFR, ERBB2, ERBB3 | MEN1 4390/4885KMT2A 2198/4885TDP1 1247/4885 |
| US-20250353853-A1 | FLAVIVIRUS INHIBITORS | SPINT2, EIF2AK2, DDX5 | MEN1 3783/4885KMT2A 876/4885TDP1 2021/4885 |
| US-20250002495-A1 | SPIRO-LACTAM NMDA MODULATORS AND METHODS OF USING SAME | GRIN1, GRIN2A, GRIN2C | MEN1 1800/4885KMT2A 1269/4885TDP1 3836/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.